| CT perfusion in oncologic imaging: a useful tool? R García-Figueiras, VJ Goh, AR Padhani, S Baleato-González, M Garrido, ... American Journal of Roentgenology 200 (1), 8-19, 2013 | 219 | 2013 |
| Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy EM Brozos-Vázquez, R Díaz-Peña, J García-González, L León-Mateos, ... Cancer Immunology, Immunotherapy 70, 1177-1188, 2021 | 66 | 2021 |
| Molecular basis of hypertension side effects induced by sunitinib G Aparicio-Gallego, FJ Afonso-Afonso, L León-Mateos, JL Fírvida-Pérez, ... Anti-Cancer Drugs 22 (1), 1-8, 2011 | 52 | 2011 |
| Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish … B Pérez-Valderrama, JAA Arija, AR Sánchez, AP Marín, PB García, ... Annals of Oncology 27 (4), 706-711, 2016 | 43 | 2016 |
| Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors L León-Mateos, J Mosquera, LA Aparicio Redox Biology 6, 421-425, 2015 | 31 | 2015 |
| Expression of Notch1 to-4 and their ligands in renal cell carcinoma: a tissue microarray study LMA Aparicio, VM Villaamil, GA Gallego, IS Caínzos, RG Campelo, ... Cancer Genomics & Proteomics 8 (2), 93-101, 2011 | 30 | 2011 |
| Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome. J Ruiz-Bañobre, I Abdulkader, U Anido, L León, R López-López, ... APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 125 (3 …, 2017 | 28 | 2017 |
| Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The … A Alcaraz, R González-López, J Morote, C De La Piedra, C Meseguer, ... British journal of cancer 109 (1), 121-130, 2013 | 28 | 2013 |
| Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study A Zapatero, A Gómez-Caamaño, MÁ Cabeza Rodriguez, ... Radiation Oncology 15, 1-7, 2020 | 27 | 2020 |
| Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients L León-Mateos, H Casas, A Abalo, M Vieito, M Abreu, U Anido, ... Oncotarget 8 (33), 54708, 2017 | 26 | 2017 |
| Detection of MET alterations using cell free DNA and circulating tumor cells from cancer patients P Mondelo-Macía, C Rodríguez-López, L Valiña, S Aguín, L León-Mateos, ... Cells 9 (2), 522, 2020 | 24 | 2020 |
| Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer MÁ Climent, L León-Mateos, AG Del Alba, B Pérez-Valderrama, ... Critical Reviews in Oncology/Hematology 96 (2), 308-318, 2015 | 22 | 2015 |
| Metastases of renal cell carcinoma to the thyroid gland with synchronous benign and malignant follicular cell-derived neoplasms C Zamarrón, I Abdulkader, MC Areses, V García-Paz, L León, ... Case Reports in Oncological Medicine 2013, 2013 | 22 | 2013 |
| Current status and future perspectives of liquid biopsy in small cell lung cancer P Mondelo-Macía, J García-González, L León-Mateos, A Castillo-García, ... Biomedicines 9 (1), 48, 2021 | 21 | 2021 |
| Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: a meta-analysis Ó Rapado-González, C Martínez-Reglero, Á Salgado-Barreira, ... Journal of Clinical Medicine 9 (5), 1305, 2020 | 21 | 2020 |
| Sunitinib: the first to arrive at first-line metastatic renal cell carcinoma S Vázquez, L León, O Fernández, M Lázaro, E Grande, L Aparicio Advances in therapy 29, 202-217, 2012 | 21 | 2012 |
| Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel O Fernández, J Afonso, S Vázquez, B Campos, M Lázaro, L León, ... Anti-cancer drugs 25 (3), 237-243, 2014 | 20 | 2014 |
| Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma J Puente, N Laínez, M Dueñas, MJ Méndez-Vidal, E Esteban, ... Oncotarget 8 (18), 30410, 2017 | 19 | 2017 |
| Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab P Mondelo‐Macía, J García‐González, L León‐Mateos, U Anido, S Aguin, ... Molecular oncology 15 (11), 2923-2940, 2021 | 18 | 2021 |
| PD-(L) 1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: a pairwise meta-analysis J García-González, J Ruiz-Bañobre, FJ Afonso-Afonso, ... Journal of Clinical Medicine 9 (7), 2093, 2020 | 18 | 2020 |
